EUVIMEDEUVIMED entdecken
Crossref

Salidroside-Loaded, TMTP1-Modified CSC-Exosomes Reprogram the PI3K/AKT/mTOR Axis to Overcome PD-1 Resistance in Breast Cancer

Faxiang Yin, Xin Jin, Ligong Zhang, Qiang Xie, Jun Qian

Cancer Research and Treatment · 14.01.2026

DOI: 10.4143/crt.2025.849 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Research and Treatment, online erschienen am 14.01.2026. Verfasst von Faxiang Yin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Anhui Medical University, Hefei, China. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 68 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To elucidate how Salidroside-loaded, oligopeptide-modified tumor exosomes (Salidroside@T-exo) rewire the PI3K/AKT/mTOR axis to remodel the immune microenvironment (IME) and reverse acquired PD-1 resistance in breast cancer. Materials and Methods: CSC-exosomes were surface-engineered with TMTP1 peptide and electroporated with Salidroside. PD-1-resistant MA782/5s-8101-R cells and an orthotopic mouse model were used. Multi-omics, flow cytometry, ELISA, immunofluorescence, in vivo imaging, and molecular assays examined immune and signaling outcomes.

Results

Salidroside@T-exo restored T-cell IFN-γ and GZMB secretion, suppressed CD8+ T-cell apoptosis, and inhibited p-PI3K/p-AKT/p-mTOR in T cells. CSC migration, invasion, and stemness (OCT4, NANOG, SOX2) were markedly reduced. Tumor growth, Ki-67 index, and CSC frequency dropped while TUNEL-positive cells rose.

Conclusion

Salidroside@T-exo reverses PD-1 blockade resistance by simultaneously inhibiting PI3K/AKT/mTOR signaling in T cells and eradicating breast CSCs, offering a clinically translatable strategy for refractory breast cancer immunotherapy.

Schlagwörter

Stichwörter der Autor:innen

Breast neoplasmsImmune microenvironmentOligopeptide-modified tumor-derived exosomesPD-1 immunotherapy resistancePI3K/AKT/mTOR signaling pathwaySalidroside-loaded

Autor:innen und Institutionen

  • Anhui Medical University, Hefei, China.
  • Department of Oncology Surgery, First Affiliated Hospital of Bengbu Medical University, Bengbu, China.

Zitieren

APA

Yin, F., Jin, X., Zhang, L., Xie, Q., & Qian, J. (2026). Salidroside-Loaded, TMTP1-Modified CSC-Exosomes Reprogram the PI3K/AKT/mTOR Axis to Overcome PD-1 Resistance in Breast Cancer. Cancer Research and Treatment. https://doi.org/10.4143/crt.2025.849

Vancouver

Yin F, Jin X, Zhang L, Xie Q, Qian J. Salidroside-Loaded, TMTP1-Modified CSC-Exosomes Reprogram the PI3K/AKT/mTOR Axis to Overcome PD-1 Resistance in Breast Cancer. Cancer Research and Treatment. 2026. doi:10.4143/crt.2025.849

BibTeX
@article{Yin2026,
  author = {Yin, Faxiang and Jin, Xin and Zhang, Ligong and Xie, Qiang and Qian, Jun},
  title = {Salidroside-Loaded, TMTP1-Modified CSC-Exosomes Reprogram the PI3K/AKT/mTOR Axis to Overcome PD-1 Resistance in Breast Cancer},
  journal = {Cancer Research and Treatment},
  year = {2026},
  doi = {10.4143/crt.2025.849}
}
Kostenlos starten →